Key takeaways: The U.S. Food and Drug Administration (FDA) has approved the first vaccine to protect babies from Respiratory Syncytial Virus (RSV) before they are born. The vaccine works by spurring the production of protective antibodies which are then transferred from mother to infant through the placenta. The approval of the RSV vaccine for pregnant women is a major breakthrough…
